Breaks Categories: News

TuesdayJun 09, 2020 10:34 am

NetworkNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) Selected to Join Russell 3000(R) Index

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, today announced that it is scheduled to join the U.S. broad-market Russell 3000 Index, which includes the 3,000 publicly traded companies on the Nasdaq and NYSE exchanges with the largest market capitalizations. According to the update and a preliminary list of additions, Genprex will join the index when FTSE Russell, a leading global index provider, reconstitutes its 2020 indices after the markets close on Friday, June 26, 2020. “The selection of Genprex for the Russell 3000(R) Index will add to the awareness…

Continue Reading

TuesdayJun 09, 2020 10:28 am

NetworkNewsBreaks – Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Announces Retirement of CFO, Names Successor

Plus Products (CSE: PLUS) (OTCQX: PLPRF), a cannabis and hemp branded products company in the U.S., today announced that its Chief Financial Officer, Jon Paul, will be retiring at the end of this month. According to the update, current Vice President of Finance, Nate Pearson, has been identified as his successor, while Paul, following his retirement, will continue in an advisory role to ensure a smooth transition. “Jon has played an integral role in our organization since the day he joined,” Jake Heimark, co-founder and CEO of Plus Products, stated in the news release. “The financial and regulatory environments in…

Continue Reading

TuesdayJun 09, 2020 10:10 am

NetworkNewsBreaks – Bullfrog Gold Corp. (CSE: BFG) (OTCQB: BFGC) (FSE: 11B) Announces Completion of 25-Hole Drill Program at Its Bullfrog Project

Bullfrog Gold Corp. (CSE: BFG) (OTCQB: BFGC) (FSE: 11B) today announced completion of a 25-hole drill program at its Bullfrog Project (the “Project”). According to the update, the Project is located in the Bullfrog Gold District, located 125 miles northwest of Las Vegas, and comprises 5,250 acres of strategic lands, established 43-101 compliant resources and prospective exploration potential. The company drilled a total of 12,520 feet (3,816 meters) and will release assay results in the coming weeks. “Our objectives focus on expanding known resources and limits of the M-S and Bullfrog pits while starting drill testing of our new Paradise…

Continue Reading

TuesdayJun 09, 2020 9:45 am

NetworkNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Announces Financial Results for Q1 2020, Provides Business Update

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, on Monday reported financial results for the quarter ended March 31, 2020 and provided a business update. “We remain steadfast in our approach to assembling a portfolio of assets that leverages our unique collection of cancer tumors to develop and market AI-based, predictive models for personalized cancer treatments that improve patient outcomes,” Dr. Carl Schwartz, Predictive Oncology CEO, stated in the news release. “Our collection of more than 150,000 cancer tumors, amassed and curated over a 10-year period, gives us a…

Continue Reading

MondayJun 08, 2020 3:28 pm

NetworkNewsBreaks – Wrap Technologies, Inc. (NASDAQ: WRTC) Closes $12.4M Financing

Wrap Technologies (NASDAQ: WRTC), an innovator of modern policing solutions, recently announced the closing of its $12.4 million financing led by existing investors. Wrap intends to utilize the net proceeds towards scaling engineering, product development and to provide working capital to meet the demand for its BolaWrap products and accessories. In addition, the company reported that Elwood Norris, the company’s founder and largest shareholder, exercised 100,000 outstanding warrants at a price of $5.00 each for $500,000. In combination with other investors’ recently exercised 2018 warrants, the warrants provided the company with more than $4.1 million of additional working capital. “I…

Continue Reading

MondayJun 08, 2020 12:28 pm

NetworkNewsBreaks – PowerBand Solutions Inc. (TSX.V: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA) Accepts USD $2.7M Investment, Completes Mission to Offer Transformative Cloud-Based Platform

PowerBand Solutions (TSX.V: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA) today announced that its wholly-owned subsidiary, PowerBand Solutions US Inc. ("PowerBand US"), is accepting an additional USD $2.7-million investment from Texas-based D&P Holdings, Inc. ("D&P"), as it prepares for June vehicle lease originations in the United States. According PowerBand CEO Kelly Jennings, PowerBand has completed its more than two-year mission to offer a cloud-based platform that will transform the buying, selling, leasing and financing of vehicles. The platform removes unnecessary middlemen in the automotive retail sector and offers cloud-based solutions allowing automotive transactions to be carried out from any location, on smart…

Continue Reading

MondayJun 08, 2020 12:21 pm

NetworkNewsBreaks – Digital Ally, Inc. (NASDAQ: DGLY) Launches Body Camera Subscription Program in Response to High Demand for Video Evidence Technology

Digital Ally (NASDAQ: DGLY), which develops, manufactures and markets advanced video recording products and other critical safety products for law enforcement, emergency management, fleet safety and security, today announced the launch of a body camera subscription program as a response to high demand for video evidence technology for police and other first responder personnel. According to the update, the program features Digital Ally’s lightweight, weather resistant FirstVu Body Camera with Mini Dock. Several subscription packages will be available, with versatility to match a department’s unique needs. “Current events are bringing widespread attention to the importance of body cameras,” Digital Ally…

Continue Reading

MondayJun 08, 2020 11:48 am

NetworkNewsBreaks – CloudCommerce, Inc. (CLWD) Eyes Strong Trend to Digital Media, Acceleration Appears to be Helped by Pandemic

CloudCommerce (OTC: CLWD), a leading provider of digital advertising solutions, today announced that in spite of the economic downturn caused by the COVID-19 pandemic, the Company has recently increased revenue from its existing client base and added new clients within the past few weeks. “As was the case with most business leaders, our management team was concerned about the economic headwinds caused by the COVID-19 pandemic,” Andrew Van Noy, CEO of CloudCommerce, stated in the news release. “However, I am pleased to announce that our recent sales efforts have resulted in newfound revenue growth for CloudCommerce. As the economy begins…

Continue Reading

MondayJun 08, 2020 11:27 am

NetworkNewsBreaks – Adaptimmune Therapeutics plc (NASDAQ: ADAP) Closes $259.3M Follow-On

Adaptimmune Therapeutics (NASDAQ: ADAP), a leader in cell therapy to treat cancer, recently closed an underwritten public offering of 20,500,000 of its American Depositary Shares (“ADSs”), including 3,075,000 additional ADSs in accordance with the full exercise of the over-allotment option granted to the underwriters, resulting in gross proceeds of approximately $259.3 million. The ADSs were sold at the public offering price of $11.00 each. The company intends to utilize the proceeds from the offering towards advancing the development of its immunotherapies into and through clinical trials and for general corporate purposes. ROTH Capital Partners acted as lead manager for the…

Continue Reading

MondayJun 08, 2020 11:11 am

NetworkNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) Engages Toronto-based Dalriada to Advance NCE IP Portfolio

Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496), a human optimization sciences company with an emphasis on ketamine and psychedelic medicine, today announced its selection of Toronto-based Dalriada Drug Discovery Inc. (“Dalriada”) to advance its new chemical entity (“NCE”) IP portfolio as it pertains to ketamine and psilocybin/psilicin molecular scaffolds. According to the update, Dalriada, a leading contract research organization (“CRO”) in the drug discovery space, will lead Champignon’s new drug discovery programs in the NCE arena and further provide integrated R&D support to accelerate the Company’s existing preclinical assets and ongoing development of proprietary delivery platforms. “It is with…

Continue Reading